Isabelle Michel Ayoub MD FASN
Glomerular Disease, Kidney & Pancreas Transplantation
Assistant Professor of Clinical Medicine
Join to View Full Profile
543 Taylor AveColumbus, OH 43203
Phone+1 614-293-4837
Fax+1 614-293-3125
Dr. Ayoub is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- SUNY Downstate Health Sciences UniversityFellowship, Nephrology, 2011 - 2013
- Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2008 - 2011
- Lebanese University School of MedicineClass of 2005
Certifications & Licensure
- OH State Medical License 2014 - 2025
- American Board of Internal Medicine Nephrology
Clinical Trials
- A Study With Imlifidase in Anti-GBM Disease Start of enrollment: 2022 Dec 22
Roles: Contact
- Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome Start of enrollment: 2023 Jan 01
Roles: Contact
Publications & Presentations
PubMed
- Semaglutide and kidney function: direct kidney protection or an artifact?Isabelle Ayoub, Germaine Wong, Richard J Glassock
Kidney International. 2025-02-01 - 1 citationsPhase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy.Brad H Rovin, Pierre M Ronco, Jack F M Wetzels, Sharon G Adler, Isabelle Ayoub
Kidney International Reports. 2024-09-01 - 4 citationsConcordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 Diabetes.Daniel Edmonston, Elizabeth Lydon, Hillary Mulder, Karen Chiswell, Zachary Lampron
JAMA Network Open. 2024-06-03
Press Mentions
- New Findings Add to Questions About Existence of Gouty NephropathyJanuary 13th, 2021
- Clinical Trials, Non-Drug Studies at the Ohio State University Wexner Medical Center Aim to Slow Kidney Disease ProgressionJanuary 24th, 2021
- New KDOQI Commentary of 2021 KDIGO Clinical Practice Guideline for Glomerular Diseases PublishedJune 23rd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: